GLOW (BPC-157 + TB-500 + GHK-Cu Blend) — Published Research

GHK-Cu (glycyl-L-histidyl-L-lysine:copper(II)) is a naturally occurring copper-binding tripeptide found in human plasma. The copper(II) ion is coordinated by the glycyl and histidyl residues in a square planar geometry. Research has characterized GHK-Cu’s effects on fibroblast gene expression, demonstrating upregulation of collagen I, decorin, and other extracellular matrix components. The peptide also modulates metalloproteinase expression and influences the balance of matrix synthesis and degradation in cell culture models.

Pickart L, Margolina A. “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.” Int J Mol Sci. 2018. PubMed

In vitro studies using human dermal fibroblasts and keratinocytes have examined copper peptide effects on cellular processes relevant to skin biology. Research demonstrates copper peptide modulation of growth factor expression including VEGF and bFGF, along with effects on glycosaminoglycan synthesis. Cell migration assays show enhanced fibroblast and keratinocyte motility in scratch wound models. These studies provide mechanistic data on copper peptide interactions with cellular signaling pathways.

Badenhorst T et al. “Copper peptide GHK-Cu modulates key genes in skin regeneration.” Cosmetics. 2016. PMC

Research has examined various peptide combinations for their effects on cellular processes including proliferation, migration, and extracellular matrix production in laboratory models. Studies combining copper peptides with other bioactive peptides investigate potential synergistic effects on collagen deposition, angiogenesis markers, and fibroblast activation. These multi-peptide formulations are characterized using cell viability assays, gene expression analysis, and functional endpoint measurements in standardized in vitro systems.

Hussain M et al. “Peptide combination strategies in skin repair and regeneration research.” J Cosmet Dermatol. 2020. PubMed